Key points are not available for this paper at this time.
Since it is known that opiates inhibit TSH secretion, we felt it to be of interest to examine the effect of leucine-enkephalin on TSH secretion. When 250 µg leucine-enkephalin was injected i.p. into male rats, the mean serum TSH level at 30 minutes was 770 ng/ml as opposed to 1134 ng/ml in the saline control group (p < 0.02). To elucidate the mechanism of the TSH-inhibiting activity of leucine-enkephalin a series of in vitro experiments were undertaken with rat hemipituitaries. This system was first validated by demonstrating TSH-releasing activity of TRH at various times. The effect of leucine-enkephalin on TRH mediated TSH release was then determined. A suppressive effect was demonstrated (11.7 ± 0.9µg TSH/ hemipit./3 hours in the TRH alone group vs. 9.9 ± 0.8 µg TSH/hemipit./3 hours in the TRH plus leucine-enkephalin group, p ± 0.05). Naloxone failed to overcome the TSH-inhibiting activity of leucine-enkephalin (14.1 ± 1.2 µg TSH/ hemipit./3 hours for TRH alone vs. 9.0 ± 0.8 µg/hemipit./3 hours in the TRH plus leucine-enkephalin plus naloxone group, p< 0.005).
May et al. (Mon,) studied this question.